AbbVie Inc.
ABBV · Mega Cap · NYSE · Healthcare · Drug Manufacturers - General
$285.60+$0.41 (+0.14%)
Market closed · opens in 1d 3hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on ABBV
Free to track. No card required. Usually ready in 10-15 minutes.
Where ABBV sits today
Price, momentum, and the numbers behind the story.
RSI (14)
70.9Overbought
03070100
Stocksbrew score
63/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Lowest
$200
Current price
$285.6
Median target
$286.5
Highest
$328
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
ROIC
Strong · Excellent capital returns
17.7%
⚠ Things to watch
Current ratio
Weak · Low cash for bills
0.81x
How it stacks up against its peers
ABBV against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $504.37B | 80.7 | +10.4% | 63 |
 | $10.93B | 20.8 | +19.7% | 78 |
 | $29.41B | 30.8 | +15.5% | 78 |
 | $4.30B | 12.2 | +13.5% | 78 |
 | $1.20T | 43.3 | +49.6% | 77 |
What is moving ABBV
Every story that touched the stock this week, newest first.